Immunotox - Two 12-Month Extensions
ID: Immunotox_OptionExtType: Special Notice
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTE OF HEALTH NIEHSMORRISVILLE, NC, 27560, USA

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

PSC

GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH (AJ12)

Original Source

https://sam.gov/opp/8b6893253d9842e5873d2ce58fc4c465/view
Timeline
    Description

    Special Notice HEALTH AND HUMAN SERVICES, DEPARTMENT OF NATIONAL INSTITUTES OF HEALTH: Immunotox - Two 12-Month Extensions
    The National Institute of Environmental Health Sciences (NIEHS) intends to extend Contract HHSN273201400017C with Burleson Research Technologies, Inc. on a sole-source basis. The purpose of this extension is to ensure the continuation of mission critical research while the NIEHS procurement team pursues the re-competition of these services under a new cost reimbursement contract. The contract will be extended for two 12-month options.
    The Division of Translational Toxicology (DTT) uses in vitro and in vivo models to evaluate the effects of chemical, physical, and biological agents on the immune system. The objective of this R&D contract is to evaluate the complete scope of immunotoxicity, including measuring immune suppression or stimulation, evaluating allergic responses, and assessing the potential of a test agent to modulate immune function. Development and validation of new and improved methodology will also be required.
    Burleson Research Technologies, Inc. is considered the only contractor that has a comprehensive understanding of the current technologies used at NIEHS and can meet the NIEHS and DTT’s needs during the two 12-month options. Awarding the contract to another source would result in substantial disruption, unnecessary costs, and unacceptable delays. By extending the contract with the incumbent contractor, the NIEHS can continue day-to-day operations and avoid disruptions to mission essential work.
    The first option will be from August 13, 2024, through August 12, 2025, and the second option will be from August 13, 2025, through August 12, 2027. The contract value will increase accordingly.
    Interested parties may submit a written capabilities statement if they believe they can fully meet the Government's requirement. The capabilities statement must be received by the response date listed in the posting. The Government will make a determination whether to compete the requirement based on the responses received.
    For any questions regarding this notice, please contact Adam Muhsin at adam.muhsin@nih.gov.

    Point(s) of Contact
    Adam Muhsin
    adam.muhsin@nih.gov
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Immunotox - Two 12-Month Extensions
    Currently viewing
    Special Notice
    Similar Opportunities
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Active
    Health And Human Services, Department Of
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    NIH-NIAID docuBridge Upgrade
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to award a sole source contract for the upgrade of the LORENZ docuBridge system from version 21.1 to version 24.2. This upgrade is crucial for maintaining regulatory compliance, adhering to industry standards, and minimizing security vulnerabilities associated with the NIAID Electronic Common Technical Document (eCTD) system, which was initially implemented using commercial off-the-shelf software from LORENZ International, LLC. The contract will include services such as system configuration, role-based training for staff, and maintaining compliance with 21 CFR Part 11 regulations, with an estimated performance period from January 20, 2025, to September 29, 2025. Interested vendors may submit their capabilities statements to Tamara McDermott at tamara.mcdermott@nih.gov within 18 days of this notice, although the government plans to proceed with a sole source award within 25 days.
    Pathology Support for the National Institute of Environmental Health Sciences
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for pathology support services for the National Institute of Environmental Health Sciences (NIEHS) under solicitation number 75N96025R00003. The procurement aims to secure comprehensive pathology-related services, including technical support, histopathological evaluations, and assistance with reporting and publication of findings, with a contract period anticipated from July 2025 to July 2026, and options for extensions up to July 2035. This initiative is crucial for enhancing NIEHS's research capabilities while ensuring compliance with federal regulations regarding human subjects and promoting inclusivity in research practices. Interested parties must submit their proposals by 4:00 PM EST on January 6, 2025, and can direct inquiries to Sue McKenzie at sue.mckenzie@nih.gov or Erica Kitzmiller at erica.kitzmiller@nih.gov.
    In Vitro Biological Reagents
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole source procurement with Becton, Dickinson and Company for various in vitro biological reagents essential for research purposes. The procurement includes specific quantities of antibodies and reagents, such as Hu CD183 BV711 and Hu IL-13 BV421, along with shipping and handling to be delivered to Gaithersburg, Maryland. This procurement is justified under the authority of 41 U.S.C. 1901 (a)(1), indicating that only one responsible source can meet the agency's requirements. Interested parties may submit a capability statement via the NIAID electronic Simplified Acquisition Submission System (eSASS) by December 30, 2024, with all submissions considered at the Government's discretion. For further inquiries, contact Leah Hinson at leah.hinson@nih.gov.
    65--Illumina Reagents and Consumables
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Heart, Lung, and Blood Institute (NHLBI), intends to award a non-competitive contract to Illumina, Inc. for the supply of "Illumina Reagents and Consumables" essential for various sequencing and genotyping systems. This procurement is driven by the unique operational needs of NIH-owned systems, as confirmed by market research indicating that only Illumina can provide the proprietary reagents necessary to maintain research integrity and support ongoing studies. The contract performance period is set from September 3, 2025, to September 2, 2030, and interested parties may submit capability statements for review by January 6, 2025; however, this is not a solicitation for proposals. For further inquiries, interested parties can contact Ethan J. Mueller at ethan.mueller@nih.gov or by phone at +1 301 496 2153.
    NCI OA Special Notice of Subcontract Opportunity at the Frederick National Laboratory for Cancer Research
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Cancer Institute (NCI), has issued a Special Notice regarding a subcontract opportunity at the Frederick National Laboratory for Cancer Research (FNLCR) aimed at enhancing laboratory practices to meet Good Clinical Laboratory Practice (GCLP) standards. The primary objective is to engage a subcontractor to evaluate current laboratory operations, identify compliance gaps, and implement improvements related to sample management, data integrity, and overall laboratory quality standards. This initiative is crucial for ensuring the integrity of testing and data management, which will facilitate the approval of new vaccine recommendations and enhance the laboratory's quality management system. Interested parties should note that this notice is for informational purposes only, with responses treated as government property, and are encouraged to monitor SAM.gov for updates. The deadline for submissions is January 3, 2025, at noon EST, and inquiries can be directed to Jennifer Gnuschke at jennifer.gnuschke@nih.gov.
    Global Life Sciences Solutions Preventative Maintenance Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a sole-source contract for preventative maintenance services for three Sepax Pro Cell Processing Systems used in cell therapy manufacturing and research. The contract will be awarded to Global Life Sciences Solutions USA LLC, the only vendor authorized to perform these services due to the proprietary nature of the equipment and the requirement for compliance with FDA regulations regarding critical equipment maintenance. The period of performance for this contract is set from January 27, 2025, to January 26, 2026, with interested parties encouraged to submit capability statements by December 28, 2024, to Sheri Eiri at sheri.eiri@nih.gov for consideration.
    NOTICE OF INTENT TO SOLE SOURCE: Preventative Maintenance Services for Nikon CSU-W1 SoRa Spinning Disk Microscope
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), through its National Cancer Institute (NCI), intends to procure sole source preventative maintenance services for a government-owned Nikon CSU-W1 SoRa Spinning Disk Microscope, which is critical for imaging work at the NCI's Laboratory of Cancer Biology and Genetics. The procurement requires comprehensive maintenance services, including routine inspections, emergency repairs, and software updates, all performed by OEM-trained technicians to ensure compliance with manufacturer specifications and uninterrupted operation of this essential research equipment. Interested vendors must submit capability statements by December 30, 2024, and must be registered in the System for Award Management (SAM) to be considered for this firm fixed-price contract, which includes a 12-month base period and four option periods. For further inquiries, vendors can contact Lena Lee, Contract Specialist, at lena.lee@nih.gov.
    Notice of Intent to Sole Source: IdeaScale Software Licenses and Maintenance
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract for IdeaScale software licenses and maintenance to Alamo City Engineering Services (ACES). The primary objective of this procurement is to acquire licenses for an online tool that facilitates crowdsourcing ideas through submission, rating, and commenting, which will be utilized across various Health and Human Services (HHS) Operation Divisions. This software is crucial for enhancing collaborative efforts and innovation within the department. Interested organizations may submit their capability statements and qualifications to Alice M. Sobsey at alice.sobsey@nih.gov by 12:00 noon EST on December 27, 2024, with the contract period spanning from March 26, 2025, to March 25, 2030, including four option years.
    NOTICE OF INTENT TO SOLE SOURCE: Preventative Maintenance Service for Zeiss Confocal and Epifluorescence Microscopes
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Cancer Institute (NCI), intends to procure preventative maintenance and emergency services for fourteen government-owned Zeiss microscopes, which are critical for cancer research conducted by the Laboratory of Cancer Biology and Genetics. The procurement will be conducted on a sole-source basis with Carl Zeiss Microscopy, LLC, the original equipment manufacturer, due to its proprietary software and the necessity for authorized service technicians to ensure compliance with manufacturer specifications. This maintenance contract is vital for maintaining the operational functionality of the microscopes, which play a significant role in biological specimen analysis. Interested parties, particularly small businesses, are invited to submit capability statements by January 6, 2025, to be considered for potential competitive procurement. For further inquiries, contact Lena Lee at lena.lee@nih.gov.